Bausch Health Announces Third Quarter 2024 Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/31/2026
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- Fed chair Warsh kicks off Jackson Hole keynote address
- PayPal tumbles as Advent, Stripe said to drop $50 bln pursuit
- Oil settles lower on clues about Fed policy, rumors of Hormuz deal
- Dollar jumps after Warsh comments, set for weekly gain
- McKesson reports cybersecurity incident affecting its information systems
- Mizuho is bullish on Broadcom ahead of Sept. 2 earnings, citing 30-quarter streak
- Wall Street ends lower after Fed Chair Warsh reaffirms inflation fight
- BioNTech ends colorectal cancer mRNA therapy trial early
- Needham sees mature node semiconductor strength in latest tracker
Bausch Health Companies (BHC) PT Raised to $11 at RBC Capital
November 1, 2024 6:18 AM EDTRBC Capital analyst Doug Miehm raised the price target on Bausch Health Companies (NYSE: BHC) to $11.00 (from $10.00) while maintaining a Sector Perform rating.
The analyst comments "BHC reported Q3 results that were ahead of estimates led by strong performance across all segments. Reported... More
